Uy Ear
Stock Analyst at Mizuho
(0.62)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Maintains: Outperform | 85 40 | 17.1 | 133.92% | 6 | Jun 18, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Neutral | 20 23 | 22.09 | 4.12% | 11 | May 19, 2025 | |
TECX Tectonic Therapeutic | Maintains: Outperform | 51 85 | 19.8 | 329.29% | 2 | May 15, 2025 | |
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 20 21 | 13.73 | 52.95% | 14 | Feb 26, 2025 | |
QURE uniQure | Maintains: Neutral | 7 20 | 13.83 | 44.61% | 4 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 1 | 0.62 | 61.29% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 40 | 28.8 | 38.89% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 16 | 9.15 | 74.86% | 2 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 10.54 | 279.51% | 1 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 23 | 9.13 | 151.92% | 3 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 116 140 | 125.44 | 11.61% | 10 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 24 | n/a | n/a | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 16 | n/a | n/a | 1 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 40 | 152.45 | -73.76% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 | n/a | n/a | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 | 1.58 | 532.91% | 1 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | 1.01 | 197.03% | 2 | Mar 1, 2023 |